Page last updated: 2024-08-21

erythromycin and Long QT Syndrome

erythromycin has been researched along with Long QT Syndrome in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.33)18.7374
1990's11 (36.67)18.2507
2000's10 (33.33)29.6817
2010's6 (20.00)24.3611
2020's2 (6.67)2.80

Authors

AuthorsStudies
Berger, FA; Bunge, JJH; de Groot, NMS; Hunfeld, NGM; van den Bemt, PMLA; van der Sijs, H; van Gelder, T; van Weteringen, W1
Danhaive, O; Dussart, A; Fobe, C; Moniotte, S; Piersigilli, F; Van Grambezen, B; Vo, C1
Bögeholz, N; Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Krawczyk, J1
Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Sterneberg, M1
Beck, J; Bode, C; Brunner, M; Franke, G; Hartmann, M; Koren, G; Odening, KE; Perez Feliz, S; Zehender, M; Ziupa, D1
Chalasani, N; Ghabril, M; Gorski, JC; Hall, SD; Juluri, R; Kim, S; Thong, N; Vuppalanchi, R1
Bitzer, M; Gregor, M; Riessen, R; Werner, CR1
Malnick, SD; Melzer, E1
Biertz, J; Breithardt, G; Bruns, HJ; Eckardt, L; Fabritz, L; Fleischer, D; Haverkamp, W; Kirchhof, P; Milberg, P; Ramtin, S; Reinsch, N1
Hanada, E; Hirota, M; Iga, T; Kotaki, H; Nakaya, H; Ohtani, H; Sato, H; Uemura, N; Yamada, Y1
Preskorn, SH1
Duff, HJ; Guo, J; Lees-Miller, JP; Teng, G; Zhan, S1
Beckmann, BM; Hinterseer, M; Irlbeck, M; Kaab, S; Ney, L; Pfeufer, A; Steinbeck, G1
Itoh, M; Itoh, Z; Kato, A; Kimura, K; Mizoguchi, K; Omura, S; Suzuki, M; Tabo, M; Takanashi, H1
Itoh, Z; Kato, A; Kimura, K; Mizoguchi, K; Omura, S; Suzuki, M; Tabo, M; Takanashi, H1
Abernethy, DP; Allareddy, RR; Dettmer, MM; Dikshteyn, M; Jeyaraj, D; Kaufman, ES; Lewis, SA; Meredith, DM; Natarajan, RN; Patel, K1
Roden, DM1
Barold, SS; Brandriss, MW; Richardson, WS1
Pressler, ML; Pride, HP; Rubart, M; Zipes, DP1
Chang, MS; Chen, SA; Chiang, CE; Hsieh, MH; Lee, SH; Tai, CT; Wen, ZC1
Antzelevitch, C; Sun, ZQ; Yan, GX; Zhang, ZQ1
Crijns, HJ; Panhuyzen-Goedkoop, NM1
Vogt, AW; Zollo, RA1
Dennis, DM; Guyton, TS; Martynyuk, AE; Morey, TE; Napolitano, CA; Raatikainen, MJ1
Pasco, J1
Ferguson, M; Jordan, L; Kent, S; Trotta, R1
Cox, BF; Gintant, GA; Limberis, JT; McDermott, JS; Wegner, CD1
Azaz-Livshits, T; Ben-Yehuda, A; Goldschmidt, N; Muszkat, M; Nir-Paz, R1
Lemery, R; Nattel, S; Ranger, S; Roy, D; Talajic, M1
Anderson, KP; Freedman, RA; Green, LS; Mason, JW1

Reviews

2 review(s) available for erythromycin and Long QT Syndrome

ArticleYear
Torsade de pointes.
    Clinical cardiology, 1993, Volume: 16, Issue:9

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Dogs; Electrocardiography; Erythromycin; Heart Rate; Histamine Antagonists; Humans; Long QT Syndrome; Torsades de Pointes

1993
Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:6

    Topics: Adult; Erythromycin; Female; Humans; Long QT Syndrome; Pneumonia; Torsades de Pointes

1994

Other Studies

28 other study(ies) available for erythromycin and Long QT Syndrome

ArticleYear
Dynamics of the QTc interval over a 24-h dose interval after start of intravenous ciprofloxacin or low-dose erythromycin administration in ICU patients.
    Pharmacology research & perspectives, 2021, Volume: 9, Issue:6

    Topics: Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Electrocardiography; Erythromycin; Female; Humans; Intensive Care Units; Long QT Syndrome; Male; Middle Aged; Prospective Studies; Risk Factors; Time Factors

2021
Torsade de pointe due to QT prolongation following erythromycin administration in a preterm infant.
    Acta cardiologica, 2022, Volume: 77, Issue:7

    Topics: Anti-Bacterial Agents; Erythromycin; Female; Humans; Infant, Newborn; Infant, Premature; Long QT Syndrome; Pregnancy; Tachycardia; Torsades de Pointes; Ureaplasma Infections

2022
Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.
    Journal of cardiovascular electrophysiology, 2018, Volume: 29, Issue:3

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Dantrolene; Disease Models, Animal; Electrocardiography; Erythromycin; Heart Rate; Heart Ventricles; Isolated Heart Preparation; Long QT Syndrome; Rabbits; Ryanodine Receptor Calcium Release Channel; Time Factors; Torsades de Pointes; Veratridine

2018
Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2018, 10-01, Volume: 20, Issue:10

    Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Antazoline; Anti-Bacterial Agents; Arrhythmias, Cardiac; Disease Models, Animal; Erythromycin; Histamine H1 Antagonists; Isolated Heart Preparation; Long QT Syndrome; Membrane Transport Modulators; Pinacidil; Rabbits; Refractory Period, Electrophysiological; Sotalol; Torsades de Pointes; Ventricular Fibrillation

2018
Pronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbits.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Action Potentials; Animals; Animals, Genetically Modified; Erythromycin; Female; Heart; Long QT Syndrome; Piperidines; Pyridines; Rabbits

2014
Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
    Journal of clinical gastroenterology, 2011, Volume: 45, Issue:7

    Topics: Administration, Oral; Anti-Bacterial Agents; Cytochrome P-450 CYP3A; Electrocardiography; Erythromycin; Humans; Intestinal Mucosa; Liver Cirrhosis; Long QT Syndrome; Portasystemic Shunt, Transjugular Intrahepatic; Risk Factors

2011
[Unexpected complication following esophageal variceal hemorrhage - Case 2/2011].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:5

    Topics: Amiodarone; Anti-Bacterial Agents; Ciprofloxacin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diagnosis, Differential; Drug Interactions; Drug Therapy, Combination; Electric Countershock; Electrocardiography, Ambulatory; Erythromycin; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Hemoglobins; Humans; Liver Cirrhosis, Alcoholic; Long QT Syndrome; Male; Middle Aged; Peptide Fragments; Recurrence; Risk Factors; Tachycardia; Torsades de Pointes

2011
Compromise of patient safety in research report.
    Journal of clinical gastroenterology, 2012, Volume: 46, Issue:2

    Topics: Anti-Bacterial Agents; Erythromycin; Humans; Liver Cirrhosis; Long QT Syndrome; Portasystemic Shunt, Transjugular Intrahepatic

2012
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Blood Pressure; Clarithromycin; Electrocardiography; Erythromycin; Heart; Heart Rate; In Vitro Techniques; Long QT Syndrome; Male; Rabbits; Time Factors; Torsades de Pointes

2002
Inhibitory effect of erythromycin on potassium currents in rat ventricular myocytes in comparison with disopyramide.
    The Journal of pharmacy and pharmacology, 2003, Volume: 55, Issue:7

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Delayed Rectifier Potassium Channels; Disopyramide; Dose-Response Relationship, Drug; Erythromycin; In Vitro Techniques; Long QT Syndrome; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Voltage-Gated; Rats; Rats, Sprague-Dawley

2003
Drug-drug interactions: proof of relevance (part I).
    Journal of psychiatric practice, 2005, Volume: 11, Issue:2

    Topics: Anti-Bacterial Agents; Antifungal Agents; Antipsychotic Agents; Cyclophilins; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Humans; Long QT Syndrome; Mental Disorders; Metronidazole

2005
Exaggerated block of hERG (KCNH2) and prolongation of action potential duration by erythromycin at temperatures between 37 degrees C and 42 degrees C.
    Heart rhythm, 2005, Volume: 2, Issue:8

    Topics: Action Potentials; Animals; Body Temperature; Cation Transport Proteins; Disease Susceptibility; Electrophysiology; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Gene Expression Regulation, Neoplastic; Long QT Syndrome; Mice; Myocytes, Cardiac; Time Factors

2005
Acute respiratory distress syndrome with transiently impaired left ventricular function and Torsades de Pointes arrhythmia unmasking congenital long QT syndrome in a 25-yr-old woman.
    British journal of anaesthesia, 2006, Volume: 97, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Echocardiography; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Female; Fluconazole; Humans; Hypokalemia; Long QT Syndrome; Mutation; Recurrence; Respiratory Distress Syndrome; Torsades de Pointes; Treatment Outcome; Ventricular Dysfunction, Left

2006
Preclinical electrophysiology assays of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin.
    The Journal of toxicological sciences, 2007, Volume: 32, Issue:3

    Topics: Action Potentials; Animals; Cell Line; Cisapride; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Gastrointestinal Agents; Gastrointestinal Motility; Guinea Pigs; Heart Atria; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Male; Potassium Channel Blockers; Rabbits; Risk Assessment; Time Factors; Torsades de Pointes; Transfection

2007
Hemodynamic and electrophysiological effects of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin in a halothane-anesthetized canine model.
    The Journal of toxicological sciences, 2007, Volume: 32, Issue:3

    Topics: Action Potentials; Anesthesia, General; Anesthetics, Inhalation; Animals; Blood Pressure; Cardiac Pacing, Artificial; Cisapride; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Halothane; Heart Rate; Infusions, Intravenous; Long QT Syndrome; Male; Models, Animal; Risk Assessment; Time Factors; Torsades de Pointes; Ventricular Function, Left; Ventricular Pressure

2007
I(Kr) channel blockade to unmask occult congenital long QT syndrome.
    Heart rhythm, 2008, Volume: 5, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Case-Control Studies; Erythromycin; Female; Humans; Long QT Syndrome; Male; Mutation; Phenotype; Potassium Channel Blockers; Potassium Channels; Propranolol

2008
Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome.
    Circulation, 1993, Volume: 88, Issue:4 Pt 1

    Topics: Action Potentials; Animals; Dogs; Electrocardiography; Erythromycin; In Vitro Techniques; Long QT Syndrome; Papillary Muscles; Potassium Channels; Purkinje Fibers; Sodium Channels

1993
Drug-induced torsades de pointes in one patient with congenital long QT syndrome.
    International journal of cardiology, 1996, Apr-19, Volume: 54, Issue:1

    Topics: Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Astemizole; Cardiac Pacing, Artificial; Electrocardiography; Erythromycin; Female; Histamine H1 Antagonists; Humans; Long QT Syndrome; Propranolol; Rhinitis; Torsades de Pointes

1996
Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
    Journal of the American College of Cardiology, 1996, Volume: 28, Issue:7

    Topics: Action Potentials; Animals; Anti-Bacterial Agents; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Endocardium; Erythromycin; Heart; Heart Ventricles; In Vitro Techniques; Long QT Syndrome; Male; Microelectrodes; Myocardium; Patch-Clamp Techniques; Pericardium; Potassium Channels; Torsades de Pointes

1996
[Iatrogenic collapse; can this be prevented?].
    Nederlands tijdschrift voor geneeskunde, 1997, Feb-08, Volume: 141, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Disopyramide; Erythromycin; Female; Humans; Long QT Syndrome; Male; Middle Aged; Sotalol; Syncope

1997
Long Q-T syndrome associated with oral erythromycin used in preoperative bowel preparation.
    Anesthesia and analgesia, 1997, Volume: 85, Issue:5

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Erythromycin; Female; Humans; Jejunoileal Bypass; Long QT Syndrome; Preoperative Care; Torsades de Pointes

1997
Ionic basis of the differential effects of intravenous anesthetics on erythromycin-induced prolongation of ventricular repolarization in the guinea pig heart.
    Anesthesiology, 1997, Volume: 87, Issue:5

    Topics: Action Potentials; Anesthetics, Intravenous; Animals; Erythromycin; Female; Guinea Pigs; Heart; Heart Ventricles; Long QT Syndrome; Male; Potassium Channels

1997
What has the patient been taking?
    Australian family physician, 1998, Volume: 27, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Chlorothiazide; Cimetidine; Diagnosis, Differential; Diuretics; Electrocardiography; Electrolytes; Erythromycin; Female; Histamine H1 Antagonists; Humans; Long QT Syndrome; Sodium Chloride Symporter Inhibitors; Terfenadine; Torsades de Pointes

1998
T wave alternans associated with HIV cardiomyopathy, erythromycin therapy, and electrolyte disturbances.
    Southern medical journal, 1998, Volume: 91, Issue:8

    Topics: Adult; Cardiomyopathies; Electrocardiography; Erythromycin; HIV Infections; Humans; Long QT Syndrome; Male; Water-Electrolyte Imbalance

1998
The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.
    Journal of cardiovascular pharmacology, 2001, Volume: 37, Issue:5

    Topics: Action Potentials; Animals; Anti-Infective Agents; Arrhythmias, Cardiac; Aza Compounds; Cisapride; Dogs; Erythromycin; Female; Fluoroquinolones; Imidazoles; In Vitro Techniques; Indoles; Long QT Syndrome; Male; Models, Biological; Moxifloxacin; Perfusion; Piperazines; Purkinje Fibers; Quinolines; Sotalol; Swine; Torsades de Pointes

2001
Compound cardiac toxicity of oral erythromycin and verapamil.
    The Annals of pharmacotherapy, 2001, Volume: 35, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Blood Cell Count; Calcium Channel Blockers; Electrocardiography; Erythromycin; Female; Heart Block; Humans; Long QT Syndrome; Verapamil

2001
Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism.
    The American journal of medicine, 1990, Volume: 89, Issue:2

    Topics: Action Potentials; Aged; Animals; Arrhythmias, Cardiac; Dogs; Electrocardiography; Erythromycin; Humans; In Vitro Techniques; Long QT Syndrome; Male; Purkinje Fibers; Quinidine; Tachycardia

1990
Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome.
    The American journal of cardiology, 1987, Jan-01, Volume: 59, Issue:1

    Topics: Adult; Arrhythmias, Cardiac; Cough; Erythromycin; Heart Ventricles; Humans; Long QT Syndrome; Male

1987